Transparency Market Research Report Added "Women Health Therapeutics Market" to its database.

Albany, NY -- (SBWire) -- 12/31/2015 --The presence of several leading pharmaceutical companies in the development of women's health therapeutics is a key factor driving the global market, states Transparency Market Research in its latest report. This research study is titled "Women's Health Therapeutics Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecasts 2011 - 2017" and is backed by unbiased, accurate, and valuable information.

The global women health therapeutics market is driven by increased research and development efforts from several pharmaceutical companies, growing awareness among physicians as well as patients, rising incidence of women's health issues, robust pipeline, and introduction of novel therapies.

Browse Full Report: http://www.transparencymarketresearch.com/women-health-therapeutics-market.html

On the basis of application, the women's health therapeutics market is segmented into post-menopausal osteoporosis, endometriosis, polycystic ovary syndrome, menopause-related disorders, infertility, gynecological cancer, and birth control. The segment of menopause-related disorders is likely to gain much momentum over the coming years. Osteoporosis is a key concern among post-menopausal women, with 20.0% of women affected by it, as per data published for the period 2014-2015. Menopause therapeutics is currently driven by hormone-based therapies. However, the introduction of non-hormone-based therapeutics is anticipated to compete against them, changing the market dynamics. The major drugs in this segment include Minastrin 24FE (Actavis plc), Actonel, Mirena (Bayer AG), Forteo, Premarin, Ortho-Tri-Cy Lo 28, Nuvaring (Merck), Reclast, Zometa (Novartis AG), Xgeva (Amgen, Inc.), and Evista (Eli Lilly and Company).

On the basis of geography, the women's health therapeutics market is divided into Europe, Asia Pacific, North America, and Rest of the World. Increased awareness regarding women's health and rise in geriatric population has enabled Europe as well as North America to become the largest markets for women health therapeutics. On the other hand, emerging economies of Asia Pacific and the Rest of the World – including the Middle East and Latin America – are anticipated to witness significant growth during the forecast period owing to rising incidence of urological disorders and growing awareness among women who seek treatment for these disorders. Supportive government initiatives and changing lifestyle also contribute towards the growth of the women's health therapeutics market.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=214

The leading players operating in the global women health therapeutics market include Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Actavis plc, Amgen, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Bayer AG, Novartis AG, Abbott Laboratories, AstraZeneca plc, and Pfizer, Inc. A detailed evaluation of the performance and contribution of these players based on attributes such as company and financial overview, recent developments, product portfolio, and business strategies has been included in the report. With the help of a SWOT analysis, each company's strengths, weaknesses, opportunities, and threats are highlighted and examined. In addition, the impact of suppliers, buyers, new entrants, competitors, and substitutes on each company has also been reviewed with the help of Porter's Five Forces analysis.

Women Health Therapeutics Market, by Application
Menopause-related disorders
Postmenopausal osteoporosis
Infertility
Endometriosis
Gynecological cancer
Polycystic ovary syndrome
Birth control

Women Health Therapeutics Market, by Geography
North America
Europe
Asia Pacific
Rest of the World

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/